These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 10887047)

  • 1. Acceleration of body clearance of diethylCarbamazine by oral activated charcoal.
    Orisakwe OE; Ilondu NA; Afonne OJ; Ofoefule SI; Orish CN
    Pharmacol Res; 2000 Aug; 42(2):167-70. PubMed ID: 10887047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of activated charcoal on diethylcarbamazine absorption in humans.
    Orisakwe OE; Ilondu ND; Afonne OJ; Ofoefule SI; Orish CN; Agbasi PU
    Am J Ther; 2001; 8(1):7-9. PubMed ID: 11304652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacokinetics, safety and tolerability of the co-administration of diethylcarbamazine and albendazole.
    Shenoy RK; Suma TK; John A; Arun SR; Kumaraswami V; Fleckenstein LL; Na-Bangchang K
    Ann Trop Med Parasitol; 2002 Sep; 96(6):603-14. PubMed ID: 12396323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of activated charcoal on rifampicin absorption in man.
    Orisakwe OE; Dioka CE; Okpogba AN; Orish CN; Ofoefule SI
    Tokai J Exp Clin Med; 1996 Feb; 21(1):51-4. PubMed ID: 9239805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the adsorption capacities of an activated-charcoal--yogurt mixture versus activated-charcoal--water slurry in vivo and in vitro.
    Hoegberg LC; Christophersen AB; Christensen HR; Angelo HR
    Clin Toxicol (Phila); 2005; 43(4):269-75. PubMed ID: 16035203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of diethylcarbamazine after single oral dose at two different times of day in human subjects.
    Bolla S; Boinpally RR; Poondru S; Devaraj R; Jasti BR
    J Clin Pharmacol; 2002 Mar; 42(3):327-31. PubMed ID: 11865970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated oral doses of activated charcoal and the clearance of tobramycin, a non-absorbable drug.
    Watson WA; Jenkins TC; Velasquez N; Schentag JJ
    J Toxicol Clin Toxicol; 1987; 25(3):171-84. PubMed ID: 3612896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acceleration of the body clearance of phenobarbital by oral activated charcoal.
    Berg MJ; Berlinger WG; Goldberg MJ; Spector R; Johnson GF
    N Engl J Med; 1982 Sep; 307(11):642-4. PubMed ID: 7050705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of gastrointestinal iron absorption by chelation from an orally administered premixed deferoxamine/charcoal slurry.
    Gomez HF; McClafferty HH; Flory D; Brent J; Dart RC
    Ann Emerg Med; 1997 Nov; 30(5):587-92. PubMed ID: 9360566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of orally administered activated charcoal on ciprofloxacin pharmacokinetics in healthy volunteers.
    Torre D; Sampietro C; Quadrelli C; Bianchi W; Maggiolo F
    Chemioterapia; 1988 Dec; 7(6):382-6. PubMed ID: 3219749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of activated charcoal on phenytoin pharmacokinetics.
    Rowden AM; Spoor JE; Bertino JS
    Ann Emerg Med; 1990 Oct; 19(10):1144-7. PubMed ID: 2221521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse reactions of 300 MG diethylcarbamazine, and in a combination of 400 MG albendazole, for a mass annual single dose treatment, in migrant workers in Phang Nga province.
    Yongyuth P; Koyadun S; Jaturabundit N; Jariyahuttakij W; Bhumiratana A
    J Med Assoc Thai; 2007 Mar; 90(3):552-63. PubMed ID: 17427535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of activated charcoal on the bioavailability of piroxicam in man.
    Laufen H; Leitold M
    Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):48-52. PubMed ID: 3957490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seromucosal transport of intravenously administered carbamazepine is not enhanced by oral doses of activated charcoal in rats.
    Eyer F; Jung N; Neuberger H; Witte A; Poethko T; Henke J; Zilker T
    Basic Clin Pharmacol Toxicol; 2008 Mar; 102(3):337-46. PubMed ID: 18248517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific gas chromatographic analysis of diethylcarbamazine in human plasma using solid-phase extraction.
    Lee S; Casteel DA; Fleckenstein L
    J Chromatogr B Biomed Sci Appl; 1997 Dec; 704(1-2):181-5. PubMed ID: 9518148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of repeated-dose activated charcoal on the pharmacokinetics of sodium valproate in healthy volunteers.
    al-Shareef A; Buss DC; Shetty HG; Ali N; Routledge PA
    Br J Clin Pharmacol; 1997 Jan; 43(1):109-11. PubMed ID: 9056061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gas chromatographic assay of diethylcarbamazine in human plasma for application to clinical pharmacokinetic studies.
    Miller JR; Fleckenstein L
    J Pharm Biomed Anal; 2001 Nov; 26(4):665-74. PubMed ID: 11516918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporary shift of microfilariae of Brugia pahangi from the lungs to muscles in Mongolian jirds, Meriones unguiculatus, after a single injection of diethylcarbamazine.
    Shigeno S; Fujimaki Y; Toriyama K; Ichinose A; Mitsui Y; Aoki Y; Kimura E
    J Parasitol; 2006 Oct; 92(5):1075-80. PubMed ID: 17152953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of oral activated charcoal to accelerate the elimination of amiodarone and chloroquine.
    Laine K; Kivistö KT; Neuvonen PJ
    Hum Exp Toxicol; 1992 Nov; 11(6):491-4. PubMed ID: 1361138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-dependent adsorptive capacity of activated charcoal for gastrointestinal decontamination of a simulated paracetamol overdose in human volunteers.
    Gude AB; Hoegberg LC; Angelo HR; Christensen HR
    Basic Clin Pharmacol Toxicol; 2010 May; 106(5):406-10. PubMed ID: 20002061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.